Pyrogen Testing Market 2021 - Analysis, Market Overview, Growth Factors, Demand, Revenue
Pyrogen testing determines the presence of endotoxin substances. Pharmaceutical and medical device industries are dedicated to R&D of more sustainable test methods for the accurate detection of pyrogenic contamination. Rabbit pyrogen test and the bacterial endotoxin test based on Limulus Amebocyte Lysate are a few of the widely used pyrogen tests. Other tests include, recombinant factor C assay and monocyte activation assay.
Market Dynamics
Initiatives to commercialize specialized reagents for pyrogen testing are to propel growth of the pyrogen testing market within the forecast period. For example, in May 2020, Lonza Sales AG partnered with Sanquin Reagents B.V. for the commercialization of a range of specialized reagents for pyrogen testing of parenteral pharmaceuticals and medical devices using the Monocyte Activation Test (MAT).
Moreover, launch of services is also likely to assist in growth of the market. For example, in October 2020, Lonza Bioscience launched PyroCell MAT System, a sustainable and reliable solution for in vitro pyrogen testing. Similarly, in November 2019, Reading Scientific Services Ltd. launched a fast, responsive and flexible sterility testing service for pharmaceutical and medical device companies.
Increasing investment in the pharmaceutical sector is expected to offer lucrative growth opportunities for players in the pyrogen testing market. For example, based on The European Federation of Pharmaceutical Industries and Associations'Key Data 2019, the pharmaceutical sector in Europe invested US$ 19, 509 million in 2000, which risen to US$ 39,895 million (est.) in 2018.
Moreover, stringent regulations regarding bacterial endotoxin testing for implants is also likely to assist in growth of the pyrogen testing market.For example, in the U.S., the Food and Drug Administration (FDA)'s guidance document titled “Submission and Report on Sterility Information in Premarket Notification [510(k)] Submissions for Devices Defined as Sterile” specifies new requirements related to bacterial endotoxin testing.
Growing concerns over utilization of animals in pyrogen testing is likely to hinder growth of the pyrogen testing market.
Competitive Analysis
Major players operating in the pyrogen testing market include, Thermo Fisher Scientific, Merck KGaA, Lonza Group, Associates of Cape Cod Inc., Charles River Laboratories Inc., GenScript, WuXi PharmaTech (Cayman), Inc., bioMérieux, Wako Chemicals USA, Inc., Sanquin, Ellab A/S, and Pyrostar
Major players in the pyrogen testing market are dedicated to adopting collaboration strategies to expand their product portfolio. For example, in May 2018, Merck and Solvias announced collaboration plans to produce PyroMAT System, a new kit for detection of pyrogen.

Comments
Post a Comment